Expression vector of guide RNA for targeting human Ku80/XRCC5 exon 6.
Alternative name | Ku80 (XRCC5) exon6 pX330-U6-Chimeric_BB-CBh-hSpCas9 |
---|---|
Clone info. | Expression vector of guide RNA for targeting human X-ray repair cross complementing 5 (Ku80/XRCC5) exon 6 (5'-GATGGCCCCTTTCGCTTAGG-3') and human codon-optimized SpCas9. |
Vector backbone | pX330-U6-Chimeric_BB-CBh-hSpCas9 (plasmid) |
Size of vector backbone | 8.5 kb |
Selectable markers | Amp^r (E. coli) |
Gene/insert name | human XRCC5 dsOligo |
Depositor|Developer | Unoki, Motoko | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] Exclusive MTA (For the DNA materials containing CRISPR/Cas9 technologies and for not-for-profit academic purpose) [Word] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) and an acknowledgment to the DEPOSITOR are requested. |
Remarks | The BIOLOGICAL RESOURCE contains CRISPR/Cas9 technologies and is not provided to for-profit organization or for for-profit research by non-profit organizations. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 専用MTA(CRISPR/Cas9内包遺伝子材料専用 非営利学術目的)をお使いください [Word] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献 (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) を引用し、謝辞の表明を必要とする。 |
備考 | 本件リソースはCRISPR/Cas9 technologyを用いたゲノム編集バイオリソースです。営利機関および非営利機関による営利目的研究には提供いたしません。 |
Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
---|---|---|---|---|
RDB17382 | Ku80 px330 | Under QC test. Please contact us. | DNA solution |
Materials & Methods section:
The Ku80 px330 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB17382). |
Reference section:
Unoki, M., Funabiki, H., Velasco, G., Francastel, C., Sasaki, H., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
Original, user report and related articles
original | Unoki, M., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP] |
---|
Featured content